APSR logo
Asian 
Pacific 
Society of 
Respirology

2015 APSR Congress

Scientific programme

This page has been reproduced from the website of the
2015 APSR Congress in Kuala Lumpur, Malaysia, 3-6 December 2015.

Oral Presentations

DAY 2 Friday 4 Dec

[Note: The entries in the table below containing a single digit, were transcribed as such from the congress website. No explanation for those numbers was found on that website.]

Time
0700-1700Registration
0700-0800Sunrise Session
0800-0815Opening ceremony
0900-1030Concurrent Oral Presentations 1D:

Asthma clinical
Presentations 1E:

Bronchoscopy Concurrent Oral
Presentations 1F:

COPD & Comorbidities
0900-0910A cross-sectional assessment of the burden of mild asthma in urban China using the 2010, 2012,and 2013 China National Health and Wellness SurveysA case series of Bronchoscopic Interventions on 3 patients with PostEndobronchial Tuberculosis airway stenoses by Malaysian PulmonologistsA Nationwide Study of CHADS2 Scores in the Prediction Acute Stroke Events in Patients with Chronic Pulmonary Obstructive Disease
0910-0920Correlation of hyperresponsiveness between the upper and lower airways in patients with allergic rhinitis and asthmaA comparison of virtual bronchoscopy versus flexible bronchoscopy in the diagnosis of tracheobronchomalaciaAutonomic response during exercise and recovery phase in people with chronic obstructive pulmonary disease (COPD)
0920-0930Patients with Moderate Asthma Presenting with Secondary HypoadrenalismA Cautionary Tale.In Vivo Findings of Probe Based Confocal Laser Endomicroscopy for Peripheral Pulmonary LesionsCOPD Patients with Resting Heart Rate of >80 Beats Per Minute Has Higher Risk of Having an Exacerbation.
0930-0940Physician perceptions and treatment of asthma in five countries: the Global Asthma Physician SurveySafety of endobronchial ultrasound with a guide sheath (EBUSGS) for peripheral pulmonary lesions? More than 1,200 our consecutive casesPsychological therapies for the treatment of anxiety disorders in COPD: A Cochrane systematic review and meta-analysis
0940-0950Vitamin D3 Supplementation Decreases Malondialdehyde Level and Change Severity in Persistent Asthma Bronchiale Patients with Vitamin D DeficiencySubgroup for which virtual bronchoscopic navigation is useful for endobronchial ultrasonography of peripheral pulmonary lesionsClinical Study on Tomographic Pulmonary Scintigraphy in Diagnosing Lung Obstructions in COPD Patients and Associated Disease Comorbidities
0950-1000Pharmacological characterization of T cellinduced bronchoconstriction responseRobotic approach to the benign mediastinal lesionsSleep apnea syndrome in patients with chronic obstructive pulmonary disease
1000-1010Validation of Malay Version of Asthma Knowledge Questionnaire by Using Classical and Modern Response Theory77
1010-1020Once-daily tiotropium Respimat® reduces exacerbation risk in patients with symptomatic asthma, independent of T helper 2 phenotype88
1020-1030Q & AQ & AQ & A
1030-1100Coffee break
1100-1230Concurrent Oral Presentations 2D:

Allergy
Concurrent Oral Presentations 2E:

Critical Care
Concurrent Oral Presentations 2F:

COPD epidemiology
1100-1110Comparison of the effects of leukotriene D4 and histamine nasal challenges on airway responsiveness and inflammation in allergic rhinitisA pregnant patient with chronic lung disease and persistent pneumothorax with incidental findings of pulmonary embolism, hypoplastic left lung and pulmonary arteryCharacteristics of chronic obstructive pulmonary disease subjects at the first visit to a pulmonary medical center in Korea: the KOrea COpd Subgroup Study team (KOCOSS)
1110-1120Effectiveness of Air Filters Intervention in Allergic rhinitisClinical Study of 40 cases with Spontaneous PneumomediastinumClassification of severity of COPD by GOLD 2011: Discordance between criteria for risk and symptoms assessment
1120-1130Impairment of regulatory T-cell is associated with maternal allergic diseases and higher atopic diseases in childhoodCase Report: Birt-Hogg-Dube syndrome with rare mutation in intron 10Coexisting bronchial asthma is an independent determinant of severe exacerbations in mildtomoderate COPD: results from a national database.
1130-1140Correlation between PM2.5 and quality of life of patients with allergic rhinitisRestrictive pulmonary dysfunction in diabetic patientsLow prevalence of obstructive lung disease in a suburban population of Malaysia: A BOLD collaborative study
1140-1150Measurement and analysis of 90 kinds food allergens specific IgG in patients with respiratory diseasesAn Asthmalike symptom caused by a foreign body aspirationOsteoporosis in patients with chronic obstructive pulmonary disease
1150-1200The analysis of hen's eggs-pecific IgE, IgG and IgG4 in children sensitized to hen's eggBronchial Embolization using an Endobronchial Watanabe Spigot for Intractable Pulmonary FistulaThe prevalence and characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
1200-121077The Efficacy of Roflumilast vs. Placebo in the Treatment of Moderate to Severe COPD in the Asian Population: A MetaAnalysis
1210-1220888
1220-1230Q & AQ & AQ & A
1400-1530Concurrent Oral Presentations 3D:

Environment, Occupation Health & Epidemiology
Concurrent Oral Presentations 3E:

Lungs function testing
Concurrent Oral Presentations 3F'

Infection Pneumonia
1400-1410The education and practice program for medical students with quantitative and qualitative fit test for respiratory protective equipmentValidation of Forced Expiratory Volume at 6 Seconds of Exhalation (FEV6) in the Detection of Small Airway DiseaseA multicenter randomized study of levofloxacin 750mg IV short course versus 500mg IV/PO sequential convention course for the treatment of communityacquired pneumonia in mainland China
1410-1420Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomised controlled trial for inpatientsAN AUDIT OF PATIENTS ADMITTED WITH A DIAGNOSIS OF "PNEUMONIA"
1420-1430Mass media interventions for preventing smoking in young people: A Cochrane systematic analysisCorrection factor for spirometry between difference ethnic groups ASPIRATION PNEUMONIA: DIAGNOSTIC CHALLENGE AND OUTCOME
1430-1440Cigarette smokemediated oxidative stress induces apoptosis in mouse lung fibroblastsReference values for spirometry in Chinese aged 4-80HOSPITALISED COMMUNITY ACQUIRED PNEUMONIA: AN AUDIT ON DIAGNOSIS AND OUTCOME
1440-1450Are we preventing Tuberculosis transmission?The ratio of maximal expiratory flow to absolute lung volume helps distinguish interstitial lung disease from other restrictive lung diseasesNasopharyngeal carriage of Streptococcus pneumoniae in aspiration pneumonia patients: a single center prospective cohort study.
1450-130066Prevalence of extrapulmonary complications and severe pneumonia associated with Mycoplasma pneumoniae pneuonia in adolescents and adults
1500-151077To study the prevalence of Legionella pneumophilia infection in patients admitted to chest diseases ward in a tertiary care hospital in northern Punjab, Pakistan.
1510-1520888
1520-1530Q & AQ & AQ & A
1530-1600Coffee break
1600-1730Concurrent Oral Presentations 4D:Concurrent Oral Presentations 4E:

Others
Concurrent Oral Presentations 4F:

Infection non-TB
1600-16101Cough Clinical Practice Guidelines: A Critical review of Scientific Evidence and RecommendationsAssociation between Pseudomonas aeruginosa infection and airway matrix metalloproteinases in bronchiectasis
1610-16202PLEURAL DISEASES REGISTRY: A WINDOW OF RESEARCH OPPORTUNITYClinical characteristics and mortality predictive factors of chronic necrotizing pulmonary aspergillosis and chronic cavitary pulmonary aspergillosis
1620-16303Student Satisfaction with Cardiopulmonary Simulation Learning Environment in Relation to Self-Confidence and Learning AchievementEvaluation of an enzyme immunoassay kit for the serodiagnosis of Mycobacterium avium complex pulmonary disease
1630-16404The Effect Of Hyperbaric Oxygen Therapy On Cryopreservative Tracheal Allograft In Rats Impacts of coexisting chronic rhinosinusitis on disease severity and risks of exacerbations in Chinese adults with bronchiectasis
1640-16505Inflammation and Metabolic Dysregulation in Malaysian Obese ChildrenImpulse oscillometry in Chinese adults with bronchiectasis
1650-17006Work related Idiopathic Pulmonary Fibrosis in Korea: Multicenter case-control studySafety of long term low dose erythromycin in chronic inflammatory lung diseases: a retrospective review in a chest hospital in Hong Kong
1700-17107Clinical characteristics of MPOANCA positive patients with pulmonary involvementSputum matrix metalloproteinase 8 and 9 and tissue inhibitor of metalloproteinase 1 in bronchiectasis: Clinical correlates and prognostic implications
1710-1720888
1720-1730Q & AQ & AQ & A
1930-2130Faculty Dinner (By Invitation only) Time

DAY 3 Saturday 5 Dec

Time
0700-1700Registration
0700-0800Sunrise Session
0900-1030Concurrent Oral Presentations 5D:

Asthma basic science
Concurrent Oral Presentations 5E:

TB Diagnostic
Concurrent Oral Presentations 5F:

COPD basic science
0900-0910Ceruloplasmin regulation of blood neutrophilic myeloperoxidase activity in asthma patients with airway hyperresponsiveness to hyposmolar stimulusClinical Significance of Delayed Sputum Smear Conversion in Patients With Pulmonary TuberculosisFactors associated with plasma level of IL33 in patients with COPD
0910-0920Early life exposure to siblings modifies the association between TLR2 polymorphisms and asthmaDoes TB incidence data in Malaysia reflect true burden? Quantifying Tuberculosis Burden and Underrepresentation in Malaysia, 1990-2014Inhibition of mTOR restores corticosteroid sensitivity in chronic obstructive pulmonary disease
0920-0930Effects of LTD4 nasal provocation on bronchial responsiveness and inflammation in patients with allergic rhinitis and asthmaPerformance of TB Diagnostic Committee (TBDC) in Certifying Disease Activity Among Smear Negative Retreatment Cases in District IV of Manila, Philippines from January 2013 to June 2014Carbonic anhydrase III gene variants and skeletal muscle atrophy in Chronic obstructive pulmonary disease
0930-0940Serelaxin is an epithelial-dependent bronchodilator and enhances βadrenoceptor-mediated relaxationRole of Gene Xpert in Exudative pleural effusionRelationship between Serum Levels of Testosterone and Severity of Chronic Obstructive Pulmonary Disease
0940-0950Sirtuin 1 gene rs2273773 C > T single nucleotide polymorphism in asthmatic patientssputum conversion in case of pulmonary tuberculosis among diabetes milletus patient-a study between control vs poorly control casesSerum angiopoietin-2 and CRP levels during COPD exacerbations
0950-1000The intervention of regulatory cells associated IL10 and TGFβ in asthma miceTurnaround Time for Smear Negative Category I Cases to Initiation of Treatment in District IV of Manila from January 2014 to December 2014Influence of gene polymorphism on biological markers in patients with asthma and COPD associated with air pollutants
1000-1010Small airway hyperresponsiveness is associated with airway remodelling in a mouse model of bronchopulmonary dysplasia7Value of fractional exhaled nitric oxide after using a beta2 bronchodilator in the differential diagnosis of bronchial asthma and chronic obstructive pulmonary disease
1010-1020Once-daily tiotropium Respimat®: safety and tolerability results from five Phase III trials in adults with symptomatic asthma88
1020-1030Q & AQ & AQ & A
1030-1100Coffee break
1100-1230Concurrent Oral Presentations 6D:

Lung Cancer
Concurrent Oral Presentations 6E:

TB - Clinical
Concurrent Oral Presentations 6F:

COPD - Clinical 1
1100-1110Cerebral infarction in advanced non-small cell lung cancerDAILY VS INTERMITTENT THERAPY IN PAEDIATRICS TB A SOUTH INDIAN STUDYChronic bronchitis is an independent risk factor for high symptom group by COPD assessment test
1110-1120Distinguishing exhaled breath of patients with lung cancer from control subjects using Simplified Chemiresistor-based Electronic Nose Technology (SCENT)Differences of Clinical and Laboratory Presentation between Positive and Negative Acid Fast Bacilli Pulmonary Tuberculosis PatientsComparison of clinical characteristics and treatment outcomes between eosinophilic and neutrophilic COPD patients with severe acute exacerbation
1120-1130Potent antimesothelioma activity of novel naftopidil analogue HUHS1015Factors limiting the scale up of isoniazid preventive therapy among HIV-infected prisoners in MalaysiaEffect of An Acute Exacerbation of COPD on Mean CAT Score
1130-1140Short Hydration using Furosemide in Cisplatine-based Chemotherapy in Patients with Lung Cancer: A Prospective Cohort StudyPolymorphism P2X7 1513A> C Gene Increase Susceptibility to Extrapulmonary Tuberculosis in Malang, IndonesiaLinguistic Validation of Malaysian Version of Bristol COPD Knowledge Questionnaire using Rasch Model
1140-1150Clinical Benefit of Comprehensive Preoperative Pulmonary Rehabilitation Including Intensive Nutritional Support for the Elderly, Low Body Weight, Lung Cancer PatientsT cells subsets versus IFNγ, TNFa and ADA in distinguishing TB From Malignant Pleural EffusionPredictability of five-time sit-to-stand (5STS) to evaluate functional capacity in people with chronic obstructive pulmonary disease (COPD)
1150-1200The association of ApaI polymorphism Vitamin D Receptor Gene and susceptibility to pulmonary tuberculosis in Indonesian Batak ethnic population.The association of ApaI polymorphism Vitamin D Receptor Gene and susceptibility to pulmonary tuberculosis in Indonesian Batak ethnic population.PULMONARY ARTERY PRESSURES & QUALITY OF LIFE IN COPD
1200-1210The Effect of Propolis on the Level of Interleukin 10 in Multidrug Resistance Tuberculosis PatientThe Effect of Propolis on the Level of Interleukin 10 in Multidrug Resistance Tuberculosis PatientIntergrated care programme for patients with chronic obstructive pulmonary disease (COPD) A randomized controlled trial
1210-1220888
1220-1230Q & AQ & AQ & A
1400-1530Concurrent Oral Presentations 7D:

NSCLC Treatment
Concurrent Oral Presentations 7E:

Case Studies
Concurrent Oral Presentations 7F:

COPD Clinical 2
1400-1410Early interdisciplinary Palliative Care for Patients with Non-Small-Cell Lung CancerKnowledge, Attitudes and Practices of Filipino Pulmonologists on Sedation of Patients on Invasive Mechanical VentilationRelationship between BODE index and the new classification of stable COPD patients according to GOLD guideline 2015
1410-1420First-line Treatment With Cytotoxic Chemotherapy Versus Epidermal Growth Factor ReceptorTyrosine Kinase Inhibitor (EGFRTKI) In Patients With EGFR Wildtype Advanced Lung AdenocarcinomaPredictors and Outcomes of Prolonged Weaning among Intubated Patients on Mechanical Ventilation Admitted to the Intensive Care UnitThe New Phenotype of Chronic Obstructive Pulmonary Disease Based on Respiratory Impedance and the Progression of Airflow imitation
1420-1430Outcome of Firstline Treatment with Epidermal Growth Factor ReceptorTyrosine Kinase Inhibitor (EGFRTKI) and Firstline Chemotherapy in Advanced Lung AdenocarcinomaRisk Factors of Prolonged Mechanical Ventilation Following Open Heart Surgery at the Philippine Heart CenterTitle Quality of Life Among Participants of a MultiCentre RCT Comparing Portable Oxygen Concentrators to Portable Oxygen Cylinders
1430-1440Phase II study of Carboplatin (CBDCA) plus weekly nabpaclitaxel (nabPTX) in elderly patients (pts) with non-small cell lung cancer (NSCLC): North Japan Lung Cancer Study Group Trial 1301A Systemic Review on Ventilator Associated PneumoniaUse of Ventilation/Perfusion Single Photon Emission Tomography (V/P SPECT) for Assessment of Ventilation in COPD
1440-1450Evaluation of EGFRTKIs efficacy according to mutation type and body size in patients with non-small cell lung cancer harboring EGFR mutations.Effect of Perfusion Fluid with Aprotinin on Ischemia-Reperfusion Injury in Lung TransplantationUse of Ventilation/Perfusion Single Photon Emission Tomography (V/P SPECT) for Assessment of COPD phenotypes and comorbidities
1450-1300Effect of antiacid medication on reduction in FVC decline with nintedanib6Glycopyrronium significantly improves lung function, health status and rescue therapy use when combined with salmeterol/fluticasone in patients with severe COPD: a subgroup analysis of the GLISTEN study
1500-1510Interim analysis of nintedanib in an open-label extension of the INPULSIS® trials (INPULSIS®ON)7Insights into the uses of noninvasive ventilation for the management of COPD exacebations over one year
1510-1520888
1520-1530Q & AQ & AQ & A
1530-1600Coffee break
1600-1730The Great Debate
1720-1730Q & AQ & AQ & A
1900-2100Gala Dinner